-
No, I don’t have COVID-19. It’s my PF cough.
Some of you may remember that I took a trip to California in February of this year (which feels like ages ago amid the COVID-19 pandemic) to spend time at Respivant; a Southern California-based biotech company on a quest to treat the chronic, dry PF cough. The passion behind this team to help patients living with pulmonary fibrosis is inspiring and their commitment to raising awareness, and trying to eliminate the IPF cough is deeply appreciated!
Recently, Respivant’s CEO Bill Gerhart wrote an article on the stigmatization of the PF cough, and how it is amplified during the COVID-19 pandemic. You can read Bill’s full article HERE.
His piece really resonates with me as a patient with this cruel lung disease, as I feel anxious every time I cough in public right now. COVID has caused a hypersensitivity to coughing in general, regardless of whether it is a cough associated with a chronic lung disease like PF, which isn’t contagious. You’re quickly glared at when you cough in public these days, which is deeply uncomfortable. Unfortunately, as Bill writes, my experience is one that is shared by many living with IPF around the world during this global pandemic and I appreciate his efforts to illuminate our struggle.
As a patient living with IPF/PF: what has your experience been dealing with a cough that has been hyper-sensitized by the general public due to COVID-19?
Log in to reply.